News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Neoadjuvant Therapy for Cutaneous Malignancies at SSO2025 – Moffitt Cancer Center
Moffitt Cancer Center/X
Mar 28, 2025, 13:04

Neoadjuvant Therapy for Cutaneous Malignancies at SSO2025 – Moffitt Cancer Center

Moffitt Cancer Center shared a post on X:

“More from INMC and Moffitt Cancer Center symposium on Neoadjuvant Therapy for Cutaneous Malignancies:

Jonathan Zager kicks off a panel on Surgical Perspectives.

    • Node localization.
    • MSLTIII & intralesional therapies.
    • Staging & special considerations.”

Neoadjuvant Therapy for Cutaneous Malignancies at SSO2025 - Moffitt Cancer Center

cancer cutaneous malignancies fight against cancer Global fight against cancer INMC Jonathan Zager Moffitt Cancer Center MSLTIII neoadjuvant therapy OncoDaily Oncology SSO2025
Special Coverage
Drugs
Aug 2, 2025, 10:49
Emrelis (Telisotuzumab vedotin) Patient Guide 2025: A New Targeted Treatment for Advanced Lung Cancer
Insight
Aug 2, 2025, 10:49
Ramy Sedhom: Away From Reflexive Treatment, Toward Outcomes That Actually Matter
Blog
Aug 2, 2025, 10:43
How an AACR Grant Enabled Madelyn Espinosa-Cotton to Study a Rare and Aggressive Type of Sarcoma
Blog
Aug 2, 2025, 10:20
What is the Main Characteristic of Monoclonal Antibodies? - Servier
Blog
Aug 2, 2025, 10:17
Mohamed Kharfan-Dabaja: Great Update on Management of CD30+ non-Hodgkin Lymphomas
Blog
Aug 2, 2025, 10:14
Got Unpublished Research in EGFRm Lung Cancer? - EGFR Resisters Research Summit
Career
Aug 2, 2025, 10:02
Mohamed A Gouda: Starting a New Role as an Assistant Professor of Medical Oncology at MD Anderson Cancer Center
Blog
Aug 2, 2025, 09:59
James Wu: My 1st Ever Lung Cancer Abstract Won an Conquer Cancer, the ASCO Foundation Merit Award
Blog
Aug 2, 2025, 09:35
Tom Powles: 5 Year Efficacy and Biomarker Data for Axitinib/Pembrolizumab in 1st Line Clear Cell RCC
Insight
Aug 2, 2025, 09:30
FASCO 2025: 44 Voices, One Mission
Blog
Aug 2, 2025, 09:28
David Gandara: ISLB Symposium in Tokyo Japan on the Role of Liquid Biopsy in Molecular Testing in a Pan-Cancer Fashion
Blog
Aug 2, 2025, 09:25
Julie Hallet: Defining High-risk Pancreas NETs